Nykode Therapeutics AS (OSL:NYKD)
4.050
+0.030 (0.75%)
Sep 18, 2026, 4:25 PM CET
Nykode Therapeutics AS Employees
Nykode Therapeutics AS had 59 employees as of June 30, 2026. The number of employees decreased by 9 or -13.24% compared to the same quarter last year.
Employees
59
Change
-9
Growth
-13.24%
Revenue / Employee
77.90K NOK
Profits / Employee
-3.85M NOK
Market Cap
1.32B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 59 | -9 | -13.24% | 59 | 0 |
| Mar 31, 2026 | 57 | -18 | -24.00% | 57 | 0 |
| Dec 31, 2025 | 59 | -77 | -56.62% | 59 | 0 |
| Sep 30, 2025 | 62 | -123 | -66.49% | 62 | 0 |
| Jun 30, 2025 | 68 | -111 | -62.01% | 68 | 0 |
| Mar 31, 2025 | 75 | -101 | -57.39% | 75 | 0 |
| Dec 31, 2024 | 136 | -37 | -21.39% | 135 | 1 |
| Sep 30, 2024 | 185 | 17 | 10.12% | 185 | 0 |
| Jun 30, 2024 | 179 | 14 | 8.48% | 179 | 0 |
| Mar 31, 2024 | 176 | 18 | 11.39% | 176 | 0 |
| Dec 31, 2023 | 173 | 22 | 14.57% | 171 | 2 |
| Sep 30, 2023 | 168 | 21 | 14.29% | 168 | 0 |
| Jun 30, 2023 | 165 | 30 | 22.22% | 165 | 0 |
| Mar 31, 2023 | 158 | 30 | 23.44% | 158 | 0 |
| Dec 31, 2022 | 151 | 51 | 51.00% | 149 | 2 |
| Sep 30, 2022 | 147 | 60 | 68.97% | 147 | 0 |
| Jun 30, 2022 | 135 | 60 | 80.00% | 135 | 0 |
| Mar 31, 2022 | 128 | 67 | 109.84% | 128 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ArcticZymes Technologies ASA | 51 |
| Oncoinvent ASA | 42 |
| Thor Medical ASA | 24 |
| Arctic Bioscience AS | 19 |
| Zelluna ASA | 15 |
| Lytix Biopharma ASA | 14 |
| EXACT Therapeutics AS | 11 |
| Circio Holding ASA | 11 |
Nykode Therapeutics AS News
- 2 days ago - Nykode Therapeutics AS Slides: H.C. Wainwright 28th Annual Global Investment Conference presentation - Filings
- 24 days ago - Nykode Therapeutics AS Earnings Call Transcript: Q2 2026 - Transcripts
- 24 days ago - Nykode Therapeutics AS Quarterly report: Q2 2026 - Filings
- 24 days ago - Nykode Therapeutics AS Slides: Q2 2026 - Filings
- 24 days ago - Nykode Therapeutics AS Slides: Company presentation - Filings
- 1 month ago - Nykode Therapeutics AS Slides: Investor presentation - Filings
- 3 months ago - Nykode Therapeutics AS Earnings Call Transcript: Q1 2026 - Transcripts
- 3 months ago - Nykode Therapeutics AS Quarterly report: Q1 2026 - Filings